Figure 3 — Underlying mechanisms of novel cuproptosis-related dihydrolipoamide branched-chain transacylase E2 (DBT) signature in sunitinib-resistant clear-cell renal cell carcinoma

Research Paper|Volume 16, Issue 3|pp. 2679–2701

Underlying mechanisms of novel cuproptosis-related dihydrolipoamide branched-chain transacylase E2 (DBT) signature in sunitinib-resistant clear-cell renal cell carcinoma

Back to articleFigure 3(3 of 7)

100%

Figure 3.Heatmap displaying the differential expression of CRGs expression in progression of ccRCC. (A) Heatmap displaying the differential expression of CRGs in normal tissues in TCGA-KIRC cohort (n = 602). (B) Expression of CRGs in normal tissues and tumors samples from the TCGA-KIRC cohort by (C) stage, (D) Tumor, (E) Node, and (F) Metastasis.